Review Article

Anxiety in Children Undergoing VCUG: Sedation or No Sedation?

Table 2

Studies comparing a sedative against another sedative, placebo, or standard treatment for VCUG. Outcomes, results, and follow-up. (NSD: no significant difference; VCUG: voiding cystourethrogram; RNC: radionuclide cystography; VUR: vesicoureteric reflux; SD: standard deviation).

Authors; year; countrySedation score outcome and resultsDistress outcome(s) and resultsUrological outcome(s) and resultsSafety outcome(s) and adverse events

I. Akil, M. Ozkol, O. Y. Ikizoglu, M. Polat, O. Y. Tuncyurek, O. Taskin, H. Yuksel; 2005; Turkey [41]Breitkopf and Buttner classification of emotional status [87], 1.87 (SD0.72) in midazolam versus 1.35 (SD0.49) in control ( ), duration of sedation is 68 min (midazolam), 28 min (chloral), Frankl behaviour rating score [88] NSD; Spielberger's state anxiety inventory [41] NSD; Houpt behaviour scale [88] of 4.93 (SD1.12) in midazolam group versus control of 4.12 (SD 1.05) in chloral group, all NSDPostvoid residual volume, VCUG grading, no difference foundNone found, defined as drop in PaO2/Sats by 5%, systolic blood pressure drop of 15 mm Hg, drop in pulse to 60 bpm

J. S. Elder, R. Longenecker; 1995; USA [43]NonePhone call at 48 h, recall, behavioural side effects; parental wishes, 97 out of 98 contacted, 56 children (60%), no recall of VCUG, 19 (21%) recalled parts, 10 remembered the procedure without negative experience, 9 recalled a negative experience, 12 out of 97 children had behavioural side effects reported after the study, 92 out of 97 (95%) parents of sedated children would request the use of midazolam againPostvoid residual volume (Bis and Slovis method [89]), no residual volume in 74% of midazolam group and 72% of control group; NSDSaturation decrease by 10%, systolic BP drop by 15 mm Hg, respective rate down to 8/min, HR down to 60/min, one child had a transient decrease in saturation requiring no intervention

D. W. Herd, K. A. McAnulty, N. A. Keene, D. E. Sommerville; 2006; New Zealand [45]NoneIndependent observer Groningen distress rating scale [90]; nursing GDRS; heart rate; parent-child interaction, 61% of placebo group experienced serious or severe distress (GDRS of 3 or 4); 26% of midazolam group had the same distress; number needed for treatment was 2.9 (95%CI 1.9–5.5)VUR grade; volume infused, no difference in volume infused ( ), no difference in VUR grading ( ), a priori power of 90%Oxygen requirement (Sats <94%), two children in midazolam group had transient desaturations to less than 94% and were given oxygen
I. Keidan, R. Zaslansky, M. Weinberg, A. Ben-Shlush, J. M. Jacobson, A. Augarten, Y. Mor; 2005; Israel [47]AVPU (alert, responds to voice, responds to pain, unresponsive)FLACC (face, legs, activity, crying, consolability) score for pain [91]; anxiety score (observer scale of behavioural distress) [92]; no difference between midazolam and nitrous oxide, number of children requiring physical restraint is 10/24 in midazolam and 2/23 for N2O ( )Time to micturition 7.2 (SD2.5) min for midazolam and 15.3 (SD 17.3), Oxygen saturation <93%, alteration in heart rate or BP by 15% from baseline, oversedation defined as “U” on the AVPU scale

P. A. Merguerian, S. T. Corbett, J. Cravero; 2006; USA [48]Not reportedNoneVoid to completion; sedated children (55%) could void to completion compared to 89% nonsedated ( )Not reported

E. Stokland, S. Andréasson, B. Jacobsson, U. Jodal, B. Ljung; 2003; Sweden [52]NoneVAS from 0 mm to 100 mm (severe problems); nurse observation VAS NSD, parent VAS, administration of midazolam more uncomfortable ( ), catheter, and overall procedure more uncomfortable with placebo ( ); parent follow-up questionnaire at 12, 24, and 48 h of “reactions,” NSDVUR grade; volume infused; ability to void; NSDNot defined, none reported

J. L. Zier, K. A. Kvam, S. C. Kurachek, M. Finkelstein; 2007; USA [59]NoneBrief behavioural distress score (BBDS) for VCUG, median age of 44 (range of 11–100) nonsedated, 11 (range of 0–67) sedated ( ), patient self-reported Wong-Baker FACES pain rating scale, 6 after catheter in nonsedated, 0 in sedated ( )Time to bladder emptying; NSDOne patient in sedated group experienced nausea, no desaturations